News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Company Profile For Digilab BioVisioN GmbH



12/22/2006 10:52:12 AM

--(BUSINESS WIRE)--In February 2006 Digilab acquired BioVisioN AG in Hannover, Germany. Digilab is globally commercializing Digilab BioVisioN GmbH’s patented Peptidomics® products and services and generating IP in this space. Digilab-BioVisioN works with companies from the pharmaceutical and diagnostics sectors, analytical instrumentation hardware, software, and consumables suppliers, and academic institutions and government agencies. Digilab has had engagements to discover new biomarkers or drug targets with such companies as AstraZeneca, Boehringer Ingelheim, Merck & Co, Novartis, Novo Nordisk, Roche Diagnostics, Abbott, Johnson & Johnson, and Solvay Pharmaceuticals.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES